"I love Cardioresearch – Hellenic Cardiovasular Research Society"

2022-10-21 04:15:48

Η Εταιρεία Δομή και ΣτόχοιΠεριοδικό & ΕκδόσειςΣυνέδριαCardioresearch TVΠαρουσίαση ΠεριστατικώνΕπικοινωνίαΕλληνικά Επώνυμες ΑπόψειςΔίκτυο Ιατρικής ΑκρίβειαςΕρευνητικά ΠρογράμματαΕνδιαφέροντα ΝέαΔιεθνή Web NewsESC NewsResearch ConsortiaPersons & CareersΚοινότητες Ελληνική ΔιασποράΑνθρωπογεωγραφία ΚλινικώνΠροϊόντα ΦαρμακευτικάΒιοτεχνολογικάΨηφιακάBlue Skies Management & LeadershipDisruptive TechnologiesEconomicsHealth PoliciesTrends Σύνδεση ΣύνδεσηHEART VESSEILS & BRAINJuly- September, 2022Το νέο τεύχος του περιοδικού Heart, Vessels & Brainμόλις κυκλοφόρησε .. Read moreEFFECTS OF TELEMEDICINETHE CASE OF HEART FAILUREΗ Τηλεϊατρική, telemonitoring καιteleconsultation αποδεικνύεται χρήσιμη στους ασθενείς με καρδιακή ανεπάρκεια. The Lancet DH September, 2022 Read moreHEART VESSELS & STROKE12-14 MΑΙΟΥ 2023ΚΑΛΑΜΑΤΑ ΞΕΝΟΔΟΧΕΙΟ FILOXENIA Read moreΕΛΛΗΝΙΚΑ ΝΟΣΟΚΟΜΕΙΑΚΑΡΔΙΟΛΟΓΙΚΕΣ ΚΛΙΝΙΚΕΣΣτοιχεία νοσηλευόμενων εβδομηντάρηδες, καπνιστές και ανεμβολίαστοι.. Read moreTAVI THROMBOSISLEAFLET SUBCLINICAL THROMBOSISΥπολογίζεται ότι 10%- 15% των ασθενών με TAVI παρουσιάζουν ασυμπτωματική θρόμβωση γλωχίνων... Read moreAORTIC STENOSIS AND TAVIUSA: 50% IN YOUNGER PATIENTSΑσθενείς με σοβαρή αορτική στένωσηηλικίας < 65 ετών, στις ΗΠΑ, φαίνεται να αντιμετωπίζονται με TAVI... Read morePASCAL vs MITRAL CLIPHEAD TO HEAD COMPARISONPascal non-inferior to Mitral Clipin degenerative MR patients. Tα νέα από το TCC/Βοστώνη... Read moreEMPAGLIFLOZIN ΙN ACUTE MIEFFECTS IN PATIENTS POST MIΒρέθηκε, ότι η χρήση Empagliflozin (10mg/ημερησίως) για 26 εβδομάδες μετά από οξύ έμφραγμα μυοκαρδίου... Read morePANTHER META-ANALYSISCAD: P2YI2 instead aspirinClopidogrel or Ticagrelor μπορεί, να είναι καλύτερη επιλογή από την ασπιρίνη για αντιαιμοπεταλιακη μονοθεραπεία, σε ασθενείς με στεφανιαία νοσο. Read moreESC CARDIOVASCULAR REALITIES 2022 Read more Χορηγοί του site Η Κοινότητα της CardiοresearchΕγγραφείτε δωρεάν μέλη and enjoy the benefits.Εγγραφείτε ΤώραIndustry LoungeΠαρουσιάζονται τρισδιάστατα (3D) περίπτερα φαρμακευτικών εταιρειών και εταιρειών βιοτεχνολογίας. Επίσης, παρουσιάζονται συνοπτικά θέματα που συνδέονται με τα εκτεθειμένα προϊόντα.Η σελίδα είναι επισκέψιμη μόνο για γιατρούς. Παρακαλούμε κάντε εγγραφή.ΠερισσότεραHeart Vessels & BrainThe cardioresearch journalΔείτε τα τεύχηCase PresentationsΠαρουσίαση ενδιαφέροντων περιστατικών καρδιοαγγειακής ιατρικής.ΠερισσότεραDigital Health & InnovationΠαρουσίαση ελληνικών και διεθνών επιστημονικών εκδηλώσεων καρδιοαγγειακής ιατρικής.ΠερισσότεραCardioresearch TVΜια συλλογή υψηλής ποιότητας επιστημονικών video.ΠερισσότεραCardio Map GreeceΠερισσότεραΝέα Τεχνολογικά ΠροϊόνταΠερισσότεραΤελευταία Νέα - Latest news.vc_custom_1607356216760{background-color: #fcfcfc !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}.vc_custom_1610534383820{margin-bottom: 10px !important;}ΌλαStrokeDigital HealthImagingHeart FailureArrhythmiasΌλαStrokeDigital HealthImagingHeart FailureArrhythmiasPlaque histology and myocardial disease in sudden coronary death: the Fingesture studySudden cardiac death (SCD) accounts for ∼50% of total cardiovascular mortality and 10–20% of all deaths.1 Most of the SCDs (70–80%) are caused by coronary artery disease (CAD), whereas non-ischaemic myocardial diseases account for approximately one-fifth of the cases, and the minority is caused by other cardiac conditions (e.g. primary arrhythmia syndromes, valve diseases, or myocarditis).2,3 Although […]ΠερισσότεραReconsidering safety and reducing barriers to MRI in patients with cardiac implantable electronic devicesNon-magnetic resonance imaging (MRI) conditional devices, leads, and abandoned leads traditionally represent a contraindication to MRI. Patients with MRI-conditional devices can safely undergo MRI if pre-defined device manufacturer steps are followed and met prior to and after performing MRI. Bhuva et al.4 provided data in support of a new contemporary approach in which patients with […]ΠερισσότεραHow delivering cardiopulmonary resuscitation and basic life support skills training through places of worship can help save lives and address health inequalitiesEarly delivery of high-quality cardiopulmonary resuscitation (CPR) and rapid defibrillation strengthen the initial links of the chain of survival and can help improve out-of-hospital cardiac arrest (OHCA) outcomes. However, health inequalities exist in OHCA survival at regional and global levels, which reduces the chances of survival, with disproportionately lower CPR delivery rates seen in areas […]ΠερισσότεραHigh-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-makingPerioperative myocardial injury evidenced by cardiac biomarker elevation is common after cardiac surgery.1,2 The fourth universal definition of myocardial infarction (UDMI)2 defines perioperative or Type 5 myocardial infarction as an elevation of cardiac troponin (cTn) of 10× the 99th percentile upper reference limit (URL) combined with (i) new pathological Q waves on electrocardiogram (ECG), (ii) flow-limiting angiographic […]ΠερισσότεραThe COVID-19 pandemic and heart failure: lessons from GUIDE-HFThe coronavirus disease 2019 (COVID-19) pandemic has led to major disruption in most aspects of human activity, including clinical trials. Normal social and professional interactions were severely limited, particularly during ‘lockdowns’. Attempting to mitigate the effects of the pandemic on clinical trials for conditions other than COVID-19, regulatory authorities, including the European Medicines Agency (EMA) […]ΠερισσότεραLong-term results of first-generation S-ICD systems: strong from the start and through the threats of timeThe advent of the subcutaneous implantable cardioverter defibrillator (S-ICD) in clinical practice was meant to provide the well-established traditional transvenous implantable cardioverter defibrillator (TV-ICD) with potentially advantageous solutions. Among them were an easier implantation technique, a simpler algorithm for life-threatening event detection only, and no need for placement of ICD components in the heart and […]ΠερισσότεραOral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational studyThere is currently no consensus on whether atrial fibrillation (AF) patients at low risk for stroke (one non-sex-related CHA2DS2-VASc point) should be treated with an oral anticoagulant. We conducted a multi-country cohort study in Sweden, Denmark, Norway, and Scotland. In total, 59 076 patients diagnosed with AF at low stroke risk were included. We assessed the […]ΠερισσότεραOptimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomesAtrial fibrillation (AF) has heterogeneous patterns of presentation concerning symptoms, duration of episodes, AF burden, and the tendency to progress towards the terminal step of permanent AF. AF is associated with a risk of stroke/thromboembolism traditionally considered dependent on patient-level risk factors rather than AF type, AF burden, or other characterizations. However, the time spent […]ΠερισσότεραNovel Technology Could Prevent Repeat Operations to Replace a Faulty Bioprosthetic Heart ValveMarch 2, 2022 – An international study led by a researcher from Tel Aviv University offers a novel technology that can assist many patients implanted with bioprosthetic heart valve by avoiding additional complicated replacement surgery. Many heart patients implanted with such valves are forced to replace it ten years later due to calcification of valve tissue. The […]ΠερισσότεραEuropean Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of CardiologyFirst published: 27 January 2022 Guideline-recommended therapies for heart failure (HF), particularly for HF with reduced ejection fraction, reduce morbidity and mortality.1 Yet observational data show geographic variation in their application in clinical practice.2–6 This disconnect between the development and the implementation of new healthcare technologies, the so-called ‘second translational gap’,7 calls for new initiatives which may […]ΠερισσότεραVentricular fibrillation: combined myocardial substrate and Purkinje ablationEuropean Heart Journal, ehab912,  Published: 09 February 2022 Since the earliest documented accounts of ventricular fibrillation (VF) >3000 years ago,1 the mechanisms responsible have been the source of ongoing debate. During the early part of the last century, both focal and re-entrant mechanisms were proposed, and more recently the re-entry mechanisms have polarized into the multiple […]ΠερισσότεραThe year in cardiovascular medicine 2021: interventional cardiologyEuropean Heart Journal, ehab884,  Published: 03 January 2022 Since last year’s report in the European Heart Journal, we have witnessed substantial progress in all aspects of interventional cardiology. Of note, the practice of interventional cardiology took place amidst successive waves of the COVID-19 pandemic, which continues to be a major burden for all healthcare professionals around […]ΠερισσότεραPoint-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study The Lancet, Published:January 05, 2022DOI:-7500(21)00256-9 Most patients who have heart failure with a reduced ejection fraction, when left ventricular ejection fraction (LVEF) is 40% or lower, are diagnosed in hospital. This is despite previous presentations to primary care with symptoms. We aimed to test an artificial intelligence (AI) algorithm applied to a single-lead ECG, recorded […]ΠερισσότεραNeuroscientific therapies for atrial fibrillationCardiovascular Research, Volume 117, Issue 7, 15 June 2021, Pages 1732- 1745, Published: 14 May 2021 The cardiac autonomic nervous system (ANS) plays an integral role in normal cardiac physiology as well as in disease states that cause cardiac arrhythmias. The cardiac ANS, comprised of a complex neural hierarchy in a nested series of […]ΠερισσότεραAtrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of CardiologyEuropean Heart Journal, ehab834,  Published: 07 December 2021 A proposed conceptual framework for understanding atrial disease. Subclinical atrial disease develops under the effect of stressors such as aging, cardio-metabolic risk factors and diseases, and genetic predisposition that activate pathogenic mechanisms, such as inflammation, endothelial and microvascular dysfunction, fibrosis, hypercoagulability and atrial stretch that in turn […]ΠερισσότεραEfficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trialEuropean Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4111–4122,  Published: 29 August 2021 Digital therapeutics is a new approach to facilitate the non-pharmacological treatment of hypertension using software programmes such as smartphone applications and/or device algorithms. Based on promising findings from a small pilot trial, the HERB Digital Hypertension 1 (HERB-DH1) pivotal […]ΠερισσότεραPredictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort StudyEuropean Heart Journal, Volume 42, Issue 40, 21 October 2021, Pages 4126–4137,  Published: 16 July 2021 Persistence with direct oral anticoagulants (DOACs) has become a concern in non-valvular atrial fibrillation (NVAF) patients, but whether this affects prognosis is rarely studied. We investigated the persistence with oral anticoagulants (OACs) and its association with prognosis among a […]Περισσότερα2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial FibrillationEP Europace, Volume 23, Issue 10, October 2021, Pages 1612–1676,  Published: 25 April 2021 Non-vitamin K antagonist oral anticoagulants (NOACs) are considered by atrial fibrillation (AF) guidelines world-wide as the preferred choice of anticoagulants to prevent stroke in patients with AF.1–4 The term NOAC has been used for many years, is used by the current European […]ΠερισσότεραFive-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II studyEuropean Heart Journal, ehab703,  Published: 07 October 2021 The SYNTAX II study evaluated the impact of advances in percutaneous coronary intervention (PCI), integrated into a single revascularization strategy, on outcomes of patients with de novo three-vessel disease. The study employed decision-making utilizing the SYNTAX score II, use of coronary physiology, thin-strut biodegradable polymer drug-eluting stents, intravascular […]ΠερισσότεραMicrovascular angina: quo tendimus?European Heart Journal, ehab534,  Published: 04 September 2021 Up to 40% of patients undergoing investigation for angina pectoris have no evidence of significant epicardial coronary disease by either elective computed tomography coronary angiography or invasive cardiac catheterization. Myocardial ischaemia can be detected in a large proportion of these patients. There is a wide spectrum of […]ΠερισσότεραAtrial fibrillation and kidney function: a bidirectional Mendelian randomization studyEuropean Heart Journal, Volume 42, Issue 29, 1 August 2021, Pages 2816 2823, The aim of this study was to investigate the causal effects between atrial fibrillation (AF) and kidney function. We performed a bidirectional summary-level Mendelian randomization (MR) analysis implementing the results from a large-scale genome-wide association study for estimated glomerular filtration rate […]ΠερισσότεραSex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient dataEuropean Heart Journal, ehab504,  Published: 02 August 2021 Data suggest that women have worse outcomes than men after coronary artery bypass grafting (CABG), but results have been inconsistent across studies. Due to the large differences in baseline characteristics between sexes, suboptimal risk adjustment due to low-quality data may be the reason for the observed differences. […]ΠερισσότεραMavacamten boosts quality of life in patients with hypertrophic cardiomyopathyPublish date: June 4, 2021 Of patients with symptomatic, obstructive hypertrophic cardiomyopathy treated with the investigational oral agent mavacamten, more than twice as many, compared with placebo, had a very large improvement from baseline in their summary quality of life score after 30 weeks of treatment in a pivotal trial with 194 patients evaluable for this […]ΠερισσότεραPHOTO GALLERY: How COVID-19 Appears on Medical ImagingMAY 27, 2021 | DAVE FORNELL, EDITOR The photo gallery below shows the variety of radiological presentations of COVID-19 (SARS-CoV-2) in medical imaging, including computed tomography (CT), radiograph X-rays, ultrasound, echocardiograms and magnetic resonance imaging (MRI). The radiology images show examples of typical COVID pneumonia in the lungs and the numerous complications the virus causes in the body in multiple […]ΠερισσότεραLeft Atrial Appendage Occlusion during Cardiac Surgery to Prevent StrokeMay 15, 2021 DOI: 10.1056/NEJMoa2101897 Surgical occlusion of the left atrial appendage has been hypothesized to prevent ischemic stroke in patients with atrial fibrillation, but this has not been proved. The procedure can be performed during cardiac surgery undertaken for other reasons. We conducted a multicenter, randomized trial involving participants with atrial fibrillation and a […]ΠερισσότεραMultivessel PCI Guided by FFR or Angiography for Myocardial InfarctionMay 16, 2021 DOI: 10.1056/NEJMoa2104650 In patients with ST-elevation myocardial infarction (STEMI) who have multivessel disease, percutaneous coronary intervention (PCI) for nonculprit lesions (complete revascularization) is superior to treatment of the culprit lesion alone. However, whether complete revascularization that is guided by fractional flow reserve (FFR) is superior to an angiography-guided procedure is unclear. In […]ΠερισσότεραValve Academic Research Consortium 3: updated endpoint definitionsEuropean Heart Journal, Volume 42, Issue 19, 14 May 2021, Pages 1825 1857, Published: 19 April 2021 The Valve Academic Research Consortium (VARC), founded in 2010, was intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these endpoints for transcatheter and surgical aortic valve clinical trials. Rapid evolution of the field, […]ΠερισσότεραLeft ventricular segmental strain and the prediction of cancer therapy-related cardiac dysfunctionEuropean Heart Journal – Cardiovascular Imaging, Volume 22, Issue 4, April 2021, Pages 418-426, Published: 18 November 2020 In a cohort of 237 women with breast cancer receiving doxorubicin with or without trastuzumab, 1151 echocardiograms were prospectively acquired over a median (Q1–Q3) of 7 (2–24) months. LV ejection fraction (LVEF) and 36 segmental strain […]ΠερισσότεραPosterior Left Atrial Adipose Tissue Attenuation Assessed by Computed Tomography and Recurrence of Atrial Fibrillation After Catheter AblationOriginally published15 Mar 2021 Circulation: Arrhythmia and Electrophysiology. 2021;14 Atrial fibrillation (AF) recurrence following catheter ablation remains high. Recent studies have shown a relation between epicardial adipose tissue and AF. epicardial adipose tissue secretes several proinflammatory and anti-inflammatory adipokines that directly interact with the adjacent myocardium. The aim of the current study was […]ΠερισσότεραMyocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED‐HFFirst published: 22 November 2020   To characterize adverse ventricular remodelling after withdrawing therapy in recovered dilated cardiomyopathy (DCM). TRED‐HF was a randomized controlled trial with a follow‐on single‐arm cross‐over phase that examined the safety and feasibility of therapy withdrawal in patients with recovered DCM over 6 months. The primary endpoint was relapse of heart failure […]ΠερισσότεραCardiology training using technologyEuropean Heart Journal, Volume 42, Issue 15, 14 April 2021, Pages 1453-1455    Published: 28 December 2020 The coronavirus disease-2019 (COVID-19) pandemic has had an unparalleled impact on cardiology training worldwide. In the next few sections, we highlight several foundational considerations for building a successful technology-enabled model in the new normal for cardiology training. […]ΠερισσότεραCryoblation as first-line treatment of new-onset atrial fibrillation?European Heart Journal, Volume 42, Issue 16, 21 April 2021, Pages 1543-1544, Published: 24 March 2021 The European Society of Cardiology Guidelines for the diagnosis and management of AF3 recommend (Class IA) rhythm control therapy for symptom and quality of life improvement in symptomatic patients with AF. However, for rhythm control, catheter ablation is […]ΠερισσότεραImmersive 3D virtual reality imaging in planning minimally invasive and complex adult cardiac surgeryEuropean Heart Journal – Digital Health, Volume 1, Issue 1, November 2020, Pages 62-70, Published: 23 November 2020 Increased complexity in cardiac surgery over the last decades necessitates more precise preoperative planning to minimize operating time, to limit the risk of complications during surgery and to aim for the best possible patient outcome. Novel, […]ΠερισσότεραNew Class of Radially Adjustable Stentrievers for Acute Ischemic StrokeOriginally published19 Mar 2021 Stroke. 2021;52:1534–1544 The Tigertriever is a novel, radially adjustable, fully visible, stentriever that permits the operator to align radial expansion with target vessel diameters. This multicenter trial compared the Tigertriever’s effectiveness and safety compared with established stent retrievers. Single arm, prospective, multicenter trial comparing the Tigertriever to efficacy and […]ΠερισσότεραLoad moreLinks Congresses & EventsForums of Excellence In Cardiovascular Medicine.vc_btn3-style-gradient-custom.vc_btn-gradient-btn-6352519246797:hover{color: #ffffff;background-color: rgba(0,0,0,0.01);border: none;background-position: 100% 0;}.vc_btn3-style-gradient-custom.vc_btn-gradient-btn-6352519246797{color: #ffffff;border: none;background-color: rgba(0,0,0,0.01);background-image: -webkit-linear-gradient(left, rgba(0,0,0,0.01) 0%, rgba(0,0,0,0.01) 50%,rgba(0,0,0,0.01) 100%);background-image: linear-gradient(to right, rgba(0,0,0,0.01) 0%, rgba(0,0,0,0.01) 50%,rgba(0,0,0,0.01) 100%);-webkit-transition: all .2s ease-in-out;transition: all .2s ease-in-out;background-size: 200% 100%;}Περισσότερα Προτεινόμενα πρόσφατα επιστημονικά άρθρα.vc_custom_1607422574593{border-left-width: 5px !important;background-color: #f5f8fe !important;border-left-color: #001949 !important;border-left-style: solid !important;}14 Οκτωβρίου, 2022Explainability and artificial intelligence in medicine VOLUME 4, ISSUE 4, E214-E215, APRIL 01, 2022Explainability and artificial intelligence in medicine VOLUME 4, ISSUE 4, E214-E215, APRIL 01, 202214 Οκτωβρίου, 2022Advancing digital health applications: priorities for innovation in real-world evidence generationVOLUME 4, ISSUE 3, E200-E206, MARCH 01, 2022Advancing digital health applications: priorities for innovation in real-world evidence generationVOLUME 4, ISSUE 3, E200-E206, MARCH 01, 202214 Οκτωβρίου, 2022Personalized medicine and the power of electronic health recordsCell. 2019 Mar 21; 177(1): 58–69.Personalized medicine and the power of electronic health recordsCell. 2019 Mar 21; 177(1): 58–69.1 Σεπτεμβρίου, 2022ESC 2022: Risk score predicts mortality for AF patients after TAVIRisk score predicts mortality for AF patients after TAVIESC 2022: Risk score predicts mortality for AF patients after TAVIRisk score predicts mortality for AF patients after TAVI1 Σεπτεμβρίου, 2022New ESC Cardio-Oncology Guideline Aims to Reduce CardiotoxicityNew ESC Cardio-Oncology Guideline Aims to Reduce Cardiotoxicity – Medscape – Aug 31, 2022.New ESC Cardio-Oncology Guideline Aims to Reduce CardiotoxicityNew ESC Cardio-Oncology Guideline Aims to Reduce Cardiotoxicity – Medscape – Aug 31, 2022.4 Ιουλίου, 2022Artificial intelligence opportunities in cardio-oncology: Overview with spotlight on electrocardiographyAm Heart J Plus. 2022 Mar;15:100129. doi: 10.1016/j.ahjo.2022.100129. Epub 2022 Apr 1.Artificial intelligence opportunities in cardio-oncology: Overview with spotlight on electrocardiographyAm Heart J Plus. 2022 Mar;15:100129. doi: 10.1016/j.ahjo.2022.100129. Epub 2022 Apr 1.4 Ιουλίου, 2022Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) StudyJACC Journals › JACC › Archives › Vol. 80 No. 1Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) StudyJACC Journals › JACC › Archives › Vol. 80 No. 15 Μαΐου, 2022Artificially Intelligent Interpretation of Stress Echocardiography: The Future Is NowJ Am Coll Cardiol Img. 2022 May, 15 (5) 728–730Artificially Intelligent Interpretation of Stress Echocardiography: The Future Is NowJ Am Coll Cardiol Img. 2022 May, 15 (5) 728–7309 Μαρτίου, 2022Same-day discharge for catheter ablation of atrial fibrillation deemed safe and feasibleCardiac Rhythm News 1st March 2022Same-day discharge for catheter ablation of atrial fibrillation deemed safe and feasibleCardiac Rhythm News 1st March 202224 Φεβρουαρίου, 2022High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep LearningJAMA Cardiol. Published online February 23, 2022. doi:10.1001/jamacardio.2021.6059High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep LearningJAMA Cardiol. Published online February 23, 2022. doi:10.1001/jamacardio.2021.60594 Φεβρουαρίου, 2022Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortalityEP Europace, Volume 24, Issue 2, February 2022, Pages 245–255, https://doi.org/10.1093/europace/euab160Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortalityEP Europace, Volume 24, Issue 2, February 2022, Pages 245–255, https://doi.org/10.1093/europace/euab16028 Ιανουαρίου, 2022The year in cardiovascular medicine 2021: interventional cardiologyEuropean Heart Journal, ehab884, https://doi.org/10.1093/eurheartj/ehab884 Published: 03 January 2022The year in cardiovascular medicine 2021: interventional cardiologyEuropean Heart Journal, ehab884, https://doi.org/10.1093/eurheartj/ehab884 Published: 03 January 202218 Ιανουαρίου, 2022Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based studyThe Lancet, VOLUME 4, ISSUE 1, E37-E45, JANUARY 01, 2022Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based studyThe Lancet, VOLUME 4, ISSUE 1, E37-E45, JANUARY 01, 202210 Ιανουαρίου, 2022Scientists on the Spot: Tracing the potential in electrophysiologyCardiovascular Research, Volume 118, Issue 1, January 2022Scientists on the Spot: Tracing the potential in electrophysiologyCardiovascular Research, Volume 118, Issue 1, January 202210 Ιανουαρίου, 2022Atrial fibrillation and stroke: are we looking in the right direction?Cardiovascular Research, Volume 118, Issue 1, January 2022Atrial fibrillation and stroke: are we looking in the right direction?Cardiovascular Research, Volume 118, Issue 1, January 202210 Ιανουαρίου, 2022Sex matters? Sex matters!Cardiovascular Research, Volume 118, Issue 1, January 2022Sex matters? Sex matters!Cardiovascular Research, Volume 118, Issue 1, January 20228 Νοεμβρίου, 2021Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction A Randomized Clinical TrialEuropace. 2021;23(9):1334-1335.Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction A Randomized Clinical TrialEuropace. 2021;23(9):1334-1335.25 Οκτωβρίου, 2021Atrial Fibrillation Ablation in Patients With Hypertrophic Cardiomyopathy: Do not Throw in the Towel too Fast!Europace. 2021;23(9):1334-1335.Atrial Fibrillation Ablation in Patients With Hypertrophic Cardiomyopathy: Do not Throw in the Towel too Fast!Europace. 2021;23(9):1334-1335.25 Οκτωβρίου, 2021International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY StudyOriginally published15 Jul 2021https://doi.org/10.1161/CIRCULATIONAHA.121.054567Circulation. 2021;144:512–523International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY StudyOriginally published15 Jul 2021https://doi.org/10.1161/CIRCULATIONAHA.121.054567Circulation. 2021;144:512–52322 Οκτωβρίου, 2021Metabolite signatures of heart failure, sleep apnoea, their interaction, and outcomes in the communityFirst published: 17 October 2021 https://doi.org/10.1002/ehf2.13631Metabolite signatures of heart failure, sleep apnoea, their interaction, and outcomes in the communityFirst published: 17 October 2021 https://doi.org/10.1002/ehf2.1363122 Οκτωβρίου, 2021Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre studyEP Europace, Volume 23, Issue 10, October 2021, Pages 1603–1611, https://doi.org/10.1093/europace/euab146 Published: 23 July 2021Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre studyEP Europace, Volume 23, Issue 10, October 2021, Pages 1603–1611, https://doi.org/10.1093/europace/euab146 Published: 23 July 202121 Οκτωβρίου, 2021Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION studyEuropean Heart Journal, ehab686, https://doi.org/10.1093/eurheartj/ehab686 Published: 13 October 2021Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION studyEuropean Heart Journal, ehab686, https://doi.org/10.1093/eurheartj/ehab686 Published: 13 October 202121 Οκτωβρίου, 2021Maternal and neonatal complications in women with congenital heart disease: a nationwide analysisEuropean Heart Journal, ehab571, https://doi.org/10.1093/eurheartj/ehab571 Published: 12 October 2021Maternal and neonatal complications in women with congenital heart disease: a nationwide analysisEuropean Heart Journal, ehab571, https://doi.org/10.1093/eurheartj/ehab571 Published: 12 October 202111 Οκτωβρίου, 2021Artificial intelligence in the diagnosis and management of arrhythmiasEuropean Heart Journal, Volume 42, Issue 38, 7 October 2021, Pages 3904–3916, https://doi.org/10.1093/eurheartj/ehab544 Published: 15 August 2021Artificial intelligence in the diagnosis and management of arrhythmiasEuropean Heart Journal, Volume 42, Issue 38, 7 October 2021, Pages 3904–3916, https://doi.org/10.1093/eurheartj/ehab544 Published: 15 August 20219 Σεπτεμβρίου, 2021The role of sex and gender differences in precision medicine: the work of the Women’s Brain ProjectEuropean Heart Journal, Volume 42, Issue 34, 7 September 2021, Pages 3215–3217, https://doi.org/10.1093/eurheartj/ehab297 Published: 16 June 2021The role of sex and gender differences in precision medicine: the work of the Women’s Brain ProjectEuropean Heart Journal, Volume 42, Issue 34, 7 September 2021, Pages 3215–3217, https://doi.org/10.1093/eurheartj/ehab297 Published: 16 June 20219 Σεπτεμβρίου, 2021Longer sleep improves cardiovascular outcomes: time to make sleep a priorityEuropean Heart Journal, Volume 42, Issue 34, 7 September 2021, Pages 3358–3360, https://doi.org/10.1093/eurheartj/ehab248 Published: 16 May 2021Longer sleep improves cardiovascular outcomes: time to make sleep a priorityEuropean Heart Journal, Volume 42, Issue 34, 7 September 2021, Pages 3358–3360, https://doi.org/10.1093/eurheartj/ehab248 Published: 16 May 20214 Αυγούστου, 2021The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profileEuropean Heart Journal, Volume 42, Issue 29, 1 August 2021, Pages 2814–2815, https://doi.org/10.1093/eurheartj/ehab320The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profileEuropean Heart Journal, Volume 42, Issue 29, 1 August 2021, Pages 2814–2815, https://doi.org/10.1093/eurheartj/ehab3203 Αυγούστου, 2021The Stanford experience of heart transplantation over five decadesEuropean Heart Journal, ehab416, https://doi.org/10.1093/eurheartj/ehab416 Published: 01 August 2021The Stanford experience of heart transplantation over five decadesEuropean Heart Journal, ehab416, https://doi.org/10.1093/eurheartj/ehab416 Published: 01 August 202119 Ιουλίου, 2021Artificial Intelligence-Enabled ECG Algorithm to Identify Patients With Left Ventricular Systolic Dysfunction Presenting to the Emergency Department With DyspneaOriginally published4 Aug 2020https://doi.org/10.1161/CIRCEP.120.008437Circulation: Arrhythmia and Electrophysiology. 2020;13:e008437Artificial Intelligence-Enabled ECG Algorithm to Identify Patients With Left Ventricular Systolic Dysfunction Presenting to the Emergency Department With DyspneaOriginally published4 Aug 2020https://doi.org/10.1161/CIRCEP.120.008437Circulation: Arrhythmia and Electrophysiology. 2020;13:e00843725 Ιουνίου, 2021Can automatic image analysis replace the pathologist in cardiac allograft rejection diagnosis?European Heart Journal, Volume 42, Issue 24, 21 June 2021, Pages 2370–2372, https://doi.org/10.1093/eurheartj/ehab226 Published: 17 May 2021Can automatic image analysis replace the pathologist in cardiac allograft rejection diagnosis?European Heart Journal, Volume 42, Issue 24, 21 June 2021, Pages 2370–2372, https://doi.org/10.1093/eurheartj/ehab226 Published: 17 May 202123 Ιουνίου, 2021A new deep learning algorithm of 12-lead electrocardiogram for identifying atrial fibrillation during sinus rhythmScientific Reports volume 11, Article number: 12818 (2021)A new deep learning algorithm of 12-lead electrocardiogram for identifying atrial fibrillation during sinus rhythmScientific Reports volume 11, Article number: 12818 (2021)9 Ιουνίου, 2021Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol loweringEuropean Heart Journal, ehab153, https://doi.org/10.1093/eurheartj/ehab153 Published: 22 March 2021Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol loweringEuropean Heart Journal, ehab153, https://doi.org/10.1093/eurheartj/ehab153 Published: 22 March 20212 Ιουνίου, 2021Electrocardiogram screening for aortic valve stenosis using artificial intelligenceEuropean Heart Journal, ehab153, https://doi.org/10.1093/eurheartj/ehab153 Published: 22 March 2021Electrocardiogram screening for aortic valve stenosis using artificial intelligenceEuropean Heart Journal, ehab153, https://doi.org/10.1093/eurheartj/ehab153 Published: 22 March 20212 Ιουνίου, 2021Impact of sex on the management and outcome of aortic stenosis patientsEuropean Heart Journal, ehab242, https://doi.org/10.1093/eurheartj/ehab242 Published: 23 May 2021Impact of sex on the management and outcome of aortic stenosis patientsEuropean Heart Journal, ehab242, https://doi.org/10.1093/eurheartj/ehab242 Published: 23 May 202117 Μαΐου, 2021What we (don’t) know about myocardial injury after COVID-19European Heart Journal, Volume 42, Issue 19, 14 May 2021, Pages 1879–1882, https://doi.org/10.1093/eurheartj/ehab145 Published: 13 March 2021What we (don’t) know about myocardial injury after COVID-19European Heart Journal, Volume 42, Issue 19, 14 May 2021, Pages 1879–1882, https://doi.org/10.1093/eurheartj/ehab145 Published: 13 March 202117 Μαΐου, 2021Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseMay 15, 2021 DOI: 10.1056/NEJMoa2102137Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseMay 15, 2021 DOI: 10.1056/NEJMoa210213714 Μαΐου, 2021An automated computational image analysis pipeline for histological grading of cardiac allograft rejectionEuropean Heart Journal, ehab241, https://doi.org/10.1093/eurheartj/ehab241 Published: 13 May 2021An automated computational image analysis pipeline for histological grading of cardiac allograft rejectionEuropean Heart Journal, ehab241, https://doi.org/10.1093/eurheartj/ehab241 Published: 13 May 202114 Μαΐου, 2021Colchicine and the heartEuropean Heart Journal, ehab221, https://doi.org/10.1093/eurheartj/ehab221 Published: 07 May 2021Colchicine and the heartEuropean Heart Journal, ehab221, https://doi.org/10.1093/eurheartj/ehab221 Published: 07 May 202114 Μαΐου, 2021Driving following defibrillator implantation: a nationwide register-linked survey studyEuropean Heart Journal, ehab253, https://doi.org/10.1093/eurheartj/ehab253 Published: 05 May 2021Driving following defibrillator implantation: a nationwide register-linked survey studyEuropean Heart Journal, ehab253, https://doi.org/10.1093/eurheartj/ehab253 Published: 05 May 202111 Μαΐου, 2021Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participantsEuropean Heart Journal, ehab225, https://doi.org/10.1093/eurheartj/ehab225 Published: 08 May 2021Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participantsEuropean Heart Journal, ehab225, https://doi.org/10.1093/eurheartj/ehab225 Published: 08 May 2021Load moreSocietyAbout UsThe JournalCardioresearch TVContactDomesticResearch & PublicationsCardio Map GreeceInternationalΝέα Τεχνολογικά ΠροϊόνταDigital Health & InnovationIndustryIndustry Lounge ©2022 Hellenic Cardiovascular Research Society | Designed by Drimon & Developed by IT Concept